Form DRSLTR - Correspondence Related to Draft Registration Statement:
SEC Accession No. 0001641172-25-005111
Filing Date
2025-04-16
Accepted
2025-04-16 17:22:11
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRSLTR 34834
  Complete submission text file 0001641172-25-005111.txt   35737
Mailing Address 29 HARAKEVET ST TEL AVIV - YAFO L3 6618003
Business Address 29 HARAKEVET ST TEL AVIV - YAFO L3 6618003 972 54-255-3956
Nasus Pharma Ltd (Filer) CIK: 0002029039 (see all company filings)

EIN.: 516022712 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: DRSLTR
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)